BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11444455)

  • 1. Perioperative management of biventricular failure after closure of a long-standing massive arteriovenous fistula.
    Nara T; Yoshikawa D; Saito S; Kadoi Y; Morita T; Goto F
    Can J Anaesth; 2001 Jun; 48(6):588-91. PubMed ID: 11444455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative management of pulmonary hypertension after heart transplantation in childhood.
    Bauer J; Dapper F; Demirakça S; Knothe C; Thul J; Hagel KJ
    J Heart Lung Transplant; 1997 Dec; 16(12):1238-47. PubMed ID: 9436136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Afterload reduction therapy with prostaglandin E1 (PGE1)].
    Yoda K; Sakai K; Saito A; Nakagawa H; Hirose M; Tanaka M
    Masui; 1989 Apr; 38(4):517-22. PubMed ID: 2724516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decompensated high-output congestive heart failure in a patient with AVF and the role of right heart catheterization: a case study.
    Malhotra K; Dhawan V; Dalal P; Ariyamuthu V; Bichu P; Botdorf J; Khanna R
    Hemodial Int; 2012 Oct; 16 Suppl 1():S58-61. PubMed ID: 23036039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
    Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
    Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation.
    Vincent JL; Carlier E; Pinsky MR; Goldstein J; Naeije R; Lejeune P; Brimioulle S; Leclerc JL; Kahn RJ; Primo G
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):33-9. PubMed ID: 1728711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amrinone, a selective phosphodiesterase III inhibitor, improves microcirculation and flap survival: a comparative study with prostaglandin E1.
    Ichioka S; Nakatsuka T; Sato Y; Shibata M; Kamiya A; Harii K
    J Surg Res; 1998 Feb; 75(1):42-8. PubMed ID: 9614855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of biventricular support with Luo-Ye pump on hemodynamics during ischemic biventricular dysfunction].
    Huang H; Xiao X; Fan R; Cheng A; Gao W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Sep; 19(3):408-11. PubMed ID: 12557509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
    Nakhoul F; Yigla M; Gilman R; Reisner SA; Abassi Z
    Nephrol Dial Transplant; 2005 Aug; 20(8):1686-92. PubMed ID: 15840664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.